Medication, Treatment

2 trials

Sponsors

Harada Ryoko, Hamada Riku

Conditions

end-stage kidney disease Kidney dysfunction, peritoneal dialysisnephrotic syndrome proteinuria, hypoproteinemia, edema

Phase 2

Randomized controlled trial of the Effectiveness of Drug Usage : Ca channel blocker for Early stage hypertension in idiopathic nephrotic syndrome

RecruitingJPRN-jRCTs031180396

Harada Ryokonephrotic syndrome proteinuria, hypoproteinemia, edema

Start: 2019-05-13Target: 40Updated: 2026-06-29

Icodextrin dialysate in pediatric peritoneal dialysis

Active, not recruitingJPRN-jRCTs031190125

Hamada Rikuend-stage kidney disease Kidney dysfunction, peritoneal dialysis

Start: 2019-11-26Target: 25Updated: 2026-06-29